Form 4: DBV Technologies CFO Granted Equity Awards

DBV Technologies S.A.'s Chief Financial Officer, Virginie Boucinha, was granted 32,000 restricted stock units and 192,000 employee stock options.

Summary

• Virginie Boucinha, Chief Financial Officer of DBV Technologies S.A. (DBVT), reported the acquisition of equity awards.
• The awards include 32,000 ordinary shares underlying a Restricted Stock Unit (RSU) award, which will vest in four equal annual installments commencing on November 21, 2026.
• Additionally, 192,000 employee stock options were granted with an exercise price of $2.9 per share, reflecting a conversion from EUR 1.00 at an exchange rate of $1.15154 as of November 21, 2025.
• These options also vest in four equal annual installments commencing on November 21, 2026, and expire on November 21, 2035.
• Following these transactions, Ms. Boucinha beneficially owns 70,000 ordinary shares and 192,000 employee stock options.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The filing reports a standard executive compensation grant, which is generally positive as it aligns management's interests with shareholders. It does not contain information that would significantly alter the company's immediate financial outlook.

Positives

• The grant of restricted stock units and employee stock options aligns the Chief Financial Officer's long-term interests with those of shareholders.
• Equity compensation is a standard practice to incentivize key executives for sustained performance and retention.

Negatives

• The vesting schedule ties a significant portion of the compensation to future service, meaning the executive must remain with the company to fully realize the value.

Risks

• The value of the granted equity awards is subject to the future performance and market price fluctuations of DBV Technologies S.A.'s ordinary shares.
• The awards are subject to forfeiture if the reporting person ceases to provide service to the company before the vesting dates.

Future Outlook

The equity awards are structured with a multi-year vesting schedule, indicating an expectation for the Chief Financial Officer's continued service and contribution to the company's long-term strategic goals and value creation.

Industry Context

The grant of equity awards to a Chief Financial Officer is a common executive compensation practice across industries, particularly in the biopharmaceutical sector, to attract, retain, and motivate key talent by aligning their financial incentives with the company's long-term performance and shareholder value.

Comparison to Industry Standards

• The structure of granting restricted stock units and employee stock options with multi-year vesting schedules is a standard compensation practice for executives in publicly traded companies, especially prevalent in growth-oriented sectors like biotechnology.
• The use of a Rule 10b5-1(c) plan for these transactions is also a common and accepted practice for insiders to manage their equity holdings in compliance with insider trading regulations.

Corporate Governance

Related Party Transactions

• The grant of 32,000 restricted stock units and 192,000 employee stock options to Virginie Boucinha, the Chief Financial Officer, constitutes a related party transaction as it involves compensation between the company and a key executive.

Stakeholder Impact

• Shareholders: The equity grants align the CFO's financial incentives with shareholder value creation, potentially leading to improved long-term performance. However, future share issuance upon vesting/exercise could lead to minor dilution.
• Employees: This reflects standard executive compensation practices, which can positively influence overall employee morale and retention strategies.

Next Steps

• The Chief Financial Officer must continue to provide service to DBV Technologies S.A. to fulfill the vesting conditions for the restricted stock units and employee stock options.
• The employee stock options may be exercised at the specified price after their respective vesting dates and before their expiration date.

Key Dates

Keywords

DBV Technologies, DBVT, Form 4, Insider Transaction, Equity Grant, Restricted Stock Units, Stock Options, Executive Compensation, CFO